Financial Ratios VYNE Therapeutics Inc.

Revenues

Cost of Goods Sold, Total

Selling General & Admin Expenses, Total

R&D Expenses

Other Operating Expenses, Total

Interest Expense, Total

Interest And Investment Income

Net Interest Expenses

Currency Exchange Gains (Loss)

Other Non Operating Income (Expenses)

Merger & Related Restructuring Charges

Impairment of Goodwill

Gain (Loss) On Sale Of Investments

In Process R&D Expenses

Other Unusual Items

Income Tax Expense

Earnings Of Discontinued Operations

Net Income to Company

Preferred Dividend and Other Adjustments

Net Income to Common Incl Extra Items

Net Income to Common Excl. Extra Items

Net EPS - Basic

Basic EPS - Continuing Operations

Basic Weighted Average Shares Outstanding

Net EPS - Diluted

Diluted EPS - Continuing Operations

Diluted Weighted Average Shares Outstanding

Normalized Basic EPS

Normalized Diluted EPS

EBITDA

EBITA

EBIT

EBITDAR

Total Revenues (As Reported)

Effective Tax Rate - (Ratio)

Current Domestic Taxes

Current Foreign Taxes

Total Current Taxes

Normalized Net Income

Interest on Long-Term Debt

Non-Cash Pension Expense

Research And Development Expense From Footnotes

Net Rental Expense, Total

Imputed Operating Lease Interest Expense

Imputed Operating Lease Depreciation

Stock-Based Comp., COGS (Total)

Stock-Based Comp., R&D Exp. (Total)

Stock-Based Comp., SG&A Exp. (Total)

Total Stock-Based Compensation

Cash And Equivalents

Short Term Investments

Accounts Receivable, Total

Other Receivables

Inventory

Prepaid Expenses

Restricted Cash

Other Current Assets, Total

Gross Property Plant And Equipment

Accumulated Depreciation

Long-term Investments

Other Long-Term Assets, Total

Accounts Payable, Total

Accrued Expenses, Total

Current Portion of Long-Term Debt

Current Portion of Leases

Unearned Revenue Current, Total

Other Current Liabilities

Long-Term Debt

Long-Term Leases

Pension & Other Post Retirement Benefits

Other Non Current Liabilities

Preferred Stock Convertible

Total Preferred Equity

Common Stock, Total

Additional Paid In Capital

Retained Earnings

Comprehensive Income and Other

Total Common Equity

ECS Total Shares Outstanding on Filing Date

ECS Total Common Shares Outstanding

Book Value / Share

Tangible Book Value

Tangible Book Value Per Share

Total Debt

Net Debt

Debt Equivalent of Unfunded Proj. Benefit Obligation

Debt Equivalent Oper. Leases

Account Code - Inventory Valuation

Inventories - Raw Materials, Total

Inventories - Work In Process, Total

Inventories - Finished Goods, Total

Machinery, Total

Full Time Employees

Part Time Employees

Net Income

Depreciation & Amortization - CF

Depreciation & Amortization, Total

(Gain) Loss From Sale Of Asset

(Gain) Loss on Sale of Investments - (CF)

Asset Writedown & Restructuring Costs

Stock-Based Compensation (CF)

Net Cash From Discontinued Operations

Other Operating Activities, Total

Change In Accounts Receivable

Change In Inventories

Change In Accounts Payable

Change in Other Net Operating Assets

Capital Expenditure

Sale of Property, Plant, and Equipment

Cash Acquisitions

Investment in Marketable and Equity Securities, Total

Other Investing Activities, Total

Long-Term Debt Issued, Total

Total Debt Issued

Long-Term Debt Repaid, Total

Total Debt Repaid

Issuance of Common Stock

Repurchase of Common Stock

Issuance of Preferred Stock

Repurchase of Preferred Stock

Other Financing Activities, Total

Foreign Exchange Rate Adjustments

Cash Interest Paid

Cash Income Tax Paid (Refund)

Change In Net Working Capital

Net Debt Issued / Repaid